242,959 Shares in Kenvue Inc. (NYSE:KVUE) Acquired by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC bought a new position in shares of Kenvue Inc. (NYSE:KVUEFree Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 242,959 shares of the company’s stock, valued at approximately $4,879,000.

Several other large investors have also bought and sold shares of the stock. Kistler Tiffany Companies LLC bought a new position in shares of Kenvue in the 2nd quarter worth about $26,000. Tamarack Advisers LP bought a new position in shares of Kenvue in the 2nd quarter worth about $26,000. Clearstead Advisors LLC bought a new position in shares of Kenvue in the 3rd quarter worth about $25,000. EverSource Wealth Advisors LLC bought a new position in shares of Kenvue in the 3rd quarter worth about $28,000. Finally, AdvisorNet Financial Inc bought a new position in shares of Kenvue in the 3rd quarter worth about $28,000. 11.33% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

KVUE has been the subject of several research analyst reports. UBS Group lifted their price objective on Kenvue from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 19th. JPMorgan Chase & Co. lowered their price objective on Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research report on Friday. Piper Sandler initiated coverage on Kenvue in a research note on Friday, November 17th. They issued a “neutral” rating and a $20.00 target price for the company. Finally, Royal Bank of Canada reduced their target price on Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $25.92.

Check Out Our Latest Stock Analysis on Kenvue

Kenvue Trading Up 1.4 %

KVUE stock opened at $19.60 on Tuesday. The company has a current ratio of 1.14, a quick ratio of 0.78 and a debt-to-equity ratio of 0.71. Kenvue Inc. has a 52-week low of $17.82 and a 52-week high of $27.80. The business has a 50-day simple moving average of $20.94 and a two-hundred day simple moving average of $21.00.

Kenvue (NYSE:KVUEGet Free Report) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.03. The business had revenue of $3.67 billion during the quarter, compared to the consensus estimate of $3.78 billion. Kenvue had a return on equity of 14.83% and a net margin of 9.87%. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. Equities analysts forecast that Kenvue Inc. will post 1.19 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, February 13th. This represents a $0.80 dividend on an annualized basis and a yield of 4.08%.

Kenvue Profile

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands.

Featured Articles

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUEFree Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.